Fox Run Management L.L.C. Trims Stock Position in Cigna Group $CI

Key Points

• Fox Run Management cut its Cigna stake by 81.3% in the second quarter, selling 3,975 shares and retaining 913 shares worth approximately $252,000. Institutional investors and hedge funds collectively own 86.99% of Cigna.
• Analysts maintain a generally positive outlook, with 15 Buy ratings and seven Holds producing a consensus “Moderate Buy” rating and an average price target of $339.45, above the reported share price of $282.24.
• Cigna exceeded quarterly earnings expectations with adjusted EPS of $7.78 versus the $7.60 consensus estimate, while revenue rose 6.7% year over year to $70.04 billion. The company also declared a quarterly dividend of $1.56 per share, representing a 2.2% annualized yield.

Fox Run Management L.L.C. decreased its stake in Cigna Group (NYSE:CI - Free Report) by 81.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 913 shares of the health services provider's stock after selling 3,975 shares during the period. Fox Run Management L.L.C.'s holdings in Cigna Group were worth $252,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CI. Assetmark Inc. grew its holdings in shares of Cigna Group by 10.0% during the first quarter. Assetmark Inc. now owns 65,662 shares of the health services provider's stock worth $17,515,000 after purchasing an additional 5,963 shares during the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Cigna Group by 41.1% in the 4th quarter. Victory Capital Management Inc. now owns 1,348,713 shares of the health services provider's stock valued at $371,206,000 after purchasing an additional 392,978 shares during the last quarter. WASHINGTON TRUST Co boosted its position in shares of Cigna Group by 297.0% in the 4th quarter. WASHINGTON TRUST Co now owns 5,296 shares of the health services provider's stock valued at $1,458,000 after purchasing an additional 3,962 shares during the period. Handelsbanken Fonder AB grew its stake in Cigna Group by 12.1% during the 2nd quarter. Handelsbanken Fonder AB now owns 82,825 shares of the health services provider's stock worth $22,833,000 after buying an additional 8,960 shares during the last quarter. Finally, CWM LLC grew its stake in Cigna Group by 12.7% during the 4th quarter. CWM LLC now owns 84,803 shares of the health services provider's stock worth $23,340,000 after buying an additional 9,566 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Sanford C. Bernstein boosted their price objective on Cigna Group from $371.00 to $381.00 and gave the company an "outperform" rating in a research note on Thursday, July 9th. Robert W. Baird set a $362.00 target price on shares of Cigna Group in a research report on Friday, July 31st. Weiss Ratings reiterated a "hold (c)" rating on shares of Cigna Group in a research report on Monday, June 1st. Wells Fargo & Company increased their price target on shares of Cigna Group from $305.00 to $307.00 and gave the stock an "equal weight" rating in a research note on Friday, July 31st. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Cigna Group from a "buy" rating to a "hold" rating and dropped their price objective for the company from $303.00 to $302.00 in a research note on Wednesday, May 20th. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $339.45.

Cigna Group Stock Performance

NYSE:CI opened at $282.24 on Friday. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The firm's fifty day moving average price is $286.02 and its 200 day moving average price is $281.28. The firm has a market cap of $74.58 billion, a price-to-earnings ratio of 11.68, a price-to-earnings-growth ratio of 0.96 and a beta of 0.29.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to analysts' expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm's revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the prior year, the company posted $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, sell-side analysts expect that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group's dividend payout ratio is 25.82%.

Insider Activity

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the company's stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Nicole S. Jones sold 19,436 shares of the firm's stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the transaction, the insider directly owned 27,256 shares of the company's stock, valued at $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company's stock.

Cigna Group Company Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source